Rhovica being one of the three winners of the Ypsomed Innovation Award
Rhovica is one of 3 winners of the Ypsomed Innovation Award 2026 for its SoNav™ technology, alongside Visienco AG and Optohive.
Rhovica winning Swiss Excellence Product Award, category startups
Rhovica Neuroimaging wins the 2025 Swiss Excellence Product Award for its patented SoNav™ system, enabling safer, real‑time brain catheter placement for acute hemorrhages, underscoring Rhovica’s leading role in innovative neuroimaging.
Rhovica Neuroimaging secures CHF 2.3M (EUR 2.5M) financing led by M2care to accelerate development of SoNav™ neurosurgical device
Rhovica Neuroimaging AG has raised CHF 2.3 million (EUR 2.5 million) in a financing round led by M2care, with participation from Kickfund, Valuemaker and several other business angels.
Rhovica Neuroimaging selected as a winner of the IMD Startup Competition
Rhovica Neuroimaging AG has been selected as one of the winners of the 27th annual IMD Startup Competition.
Collaboration between Rhovica Neuroimaging and M2care for the Advancement of Neurosurgery
Rhovica Neuroimaging and M2care have entered into a strong partnership to support the development of the startup and its technology. Through this contractual agreement, M2care provides both financial support as well as operational and strategic
Rhovica Winning Helbling Venture Challenge
On September 13, 2024, the first edition of the Helbling Venture Challenge culminated in an intense final round, where five groundbreaking startups – Resmonics, Incontalert, Earlysight, Rhovica, and Lighthousetech – competed for the top spot.
Rhovica Neuroimaging wins CHF 150,000 to develop catheter that reduces risk in lifesaving neurosurgical procedures
Rhovica Neuroimaging is developing a new external ventricular drainage catheter (EVD). Called SoNav, it has integrated sensors allowing for the safe, fast, and cost-efficient catheter placement and monitoring of brain ventricles. Their product addresses the high risk of a common neurosurgical intervention. The startup was awarded CHF 150,000 as a winner of Venture Kick’s third stage.
CHF 40,000 for a NMR-based fragment screening platform and miniature sensors in the EVD
NexMR and Rhovica Neuroimaging win Venture Kick’s second stage of financial and entrepreneurial support. Their projects aim to facilitate the study of challenging systems and assist biotechs in their journey to address unmet medical needs, enable a safe and fast external ventricular drain insertion that prevents devastating complications.
Startups developing microwave passive devices, a NMR-based fragment screening platform, a new way to play videogames, miniature sensors in the EVD, an handwriting iPad app for children, and radiation hard silicon carbide sensors each win CHF 10,000
MinWave Technologies, NexMR, OVOMIND, Rhovica Neuroimaging, School Rebound, and SenSiC win Venture Kick’s first stage of financial and entrepreneurial support.